Clinical trial
Randomized Study to Evaluate the Efficacy and Safety of Two Endovenous Insulin Protocols and a Subcutaneous Insulin Protocol in Critically Ill Patients
NCT00410852 is registered in ClinicalTrials.gov with Hospital Israelita Albert Einstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study to Evaluate the Efficacy and Safety of Two Endovenous Insulin Protocols and a Subcutaneous Insulin Protocol in Critically Ill Patients
- Lead sponsor
- Hospital Israelita Albert Einstein
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- March 31, 2007
- Enrollment
- 168 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
intensive care